Enrolling by Invitation
An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007
NCT06075537
- Conditions
- Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +22 more
- Locations
-
- UCSF Benioff Children's Hospital Oakland Oakland, California, United States
- Ann and Robert H Lurie Children's Hospital of Chicago Chicago, Illinois, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- UNC Children's Research Institute Chapel Hill, North Carolina, United States